Nectar Lifesciences Q3 FY11 Results : Net profit rises 17.48%

by khalid on 18/01/2011 · 0 comments

Chandigarh based Nectar Lifesciences is a manufacturer of sterile and oral range of bulk drug antibiotics. The company has posted a net profit for the period Q3 (ending Dec 10) of the current fiscal (FY11). During the said quarter, net profit rose 17.48% to Rs 30.21 crores in comparison to Rs 25.71 of Q3 (ending Dec 09) of previous year(FY10).

The company informed the market that the net sales rose 32.38% to Rs 320.43 crores in Q3 FY11 when compared with the same quarter Q3 FY10 of previous year. Company’s operating margins are near historic high at 28%. TCS has added 35 new clients during the quarter Q3 FY11.

Share’s Data :
BSE Code : 532649
Mkt. Cap: Rs 610.10 Crores
Nectar Lifesciences share’s CMP is Rs 27.20 on 17th Jan 2010.

Stay tuned to BelltheBull Blog for more news on Nectar Lifesciences Limited !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: